The impact of age on ablation outcomes in AF-mediated cardiomyopathy.
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S.
Segan L, et al.
J Cardiovasc Electrophysiol. 2023 Oct;34(10):2065-2075. doi: 10.1111/jce.16052. Epub 2023 Sep 11.
J Cardiovasc Electrophysiol. 2023.
PMID: 37694615
Baseline comorbidities, LVEF (34 9 vs. 33 8 65 years, p = .686), atrial and ventricular dimensions (left atrial volume index: 55 21 vs. 56 14 mL/m(2) age 65, p = .834; indexed left ventricular end-diastolic volume: 108 40 vs. 104 28 mL/m(2) age 65, p = .681), pharmacotherapy and …
Baseline comorbidities, LVEF (34 9 vs. 33 8 65 years, p = .686), atrial and ventricular dimensions (left atrial volume index: 55 21 vs. 56 1 …